Dietary calcium modulates Mycobacterium paratuberculosis infection in beige mice

Veterinary Immunology and Immunopathology

Volumn 66, Issue 3-4, 1998, Pages 377-390

  Stabel, J R ^a   Goff, J P ^a   R Ackermann, Mark ^b  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Calcium; Mice; Mycobacterium paratuberculosis

Indexed keywords

CALCITRIOL; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM METABOLISM; COLONY FORMING UNIT; CONTROLLED STUDY; MOUSE; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PARATUBERCULOSIS;

ANIMALS; CALCITRIOL; CALCIUM, DIETARY; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM PARATUBERCULOSIS; PARATUBERCULOSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS;

EID: 0032509338     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00196-2     Document Type: Article

References (26)

1. Abbasi A.A., Chemplavil J.K., Farah S., Muller B.F., Arnstein A.R. Hypercalcemia in active pulmonary tuberculosis. Ann. Intern. Med. 90:1979;324-328.
2. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 72:1983;1856-1860.
3. 3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J. Exp. Med. 161:1985;755-765.
4. Adams J.S., Modlin R.L., Diz M.M., Barnes P.F. Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculosis pleural effusion fluid. J. Clin. Endocrinol. Metab. 69:1989;457-460.
5. Barbour G.L., Coburn J.W., Slatopolsky E., Norman A.W., Horst R.L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N. Engl. J. Med. 305:1981;440-443.
6. Bell N.H., Gill J.R. Jr., Bartter F.C. On the abnormal calcium absorption in sarcoidosis: evidence of increased sensitivity to vitamin D. Am. J. Med. 36:1964;500-513.
7. 3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am. Rev. Respir. Dis. 138:1988;984-989.
8. 3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J. Clin. Invest. 85:1990;1588-1593.
9. Chiodini R.J., Van Kruiningen H.J., Merkal R.S. Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet. 74:1984;218-262.
10. Curtis C.R., Erb H.N., Sniffen C.J., Smith R.D., Powers P.A., Smith M.C., White M.E., Hillman R.B., Pearson E.J. Association of parturient hypocalcemia with eight periparturient disorders in Holstein cows. J. Am. Vet. Med. Assoc. 183:1983;559-561.
11. Davies, P.D.O., 1985. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 66, 301-306.
12. Gkonos P.J., London R., Hendler E.D. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N. Engl. J. Med. 311:1984;1683-1685.
13. Kopecky K.E. Distribution of paratuberculosis in Wisconsin by soil region. J. Am. Vet. Med. Assoc. 170:1977;320-344.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
15. Papapoulos S.E., Clemens T.L., Frather L.J., Lewin I.G., Sandler L.M., O'Riorrdan J.L.H. 1,25-Dihydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoidosis. Lancet. 1:1979;627-630.
16. 3 levels in a dialysis patient with disseminated tuberculosis. Nephron. 46:1987;377-379.
17. Reiner M., Sigurdsson G., Nunziata V., Malik M.A., Poole G.W., Joplin G.F. Abnormal calcium metabolism in normocalcaemic sarcoidosis. Br. Med. J. 2:1976;1473-1476.
18. Reinhardt T.A., Hustmeyer F.G. Role of vitamin D in the immune system. J. Dairy Sci. 70:1987;952-962.
19. 3 not requiring HPLC: application to clinical studies. J. Clin. Endocrinol. Metab. 58:1984;91-98.
20. Rigby W.F.C. The immunobiology of vitamin D. Immunol. Today. 9:1988;54-58.
21. Ryzen E., Rea T.H., Singer F.R. Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. Am. J. Med. 84:1988;325-329.
22. Shai F., Baker R.K., Addrizzo J.R., Wallach S. Hypercalcemia in mycobacterial infection. J. Clin. Endocrinol. 34:1972;251-256.
23. 3 infusion modulate immune responses during Mycobacterium paratuberculosis infection in beige mice. Vet. Immunol. Immunopathol. 50:1996;127-143.
24. Stoekle J.D., Hardy H.L., Weber A.L. Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. Am. J. Med. 46:1969;545-561.
25. Van Snick J., Vink A., Cayphas S., Ugttenhove C. Interleukin HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas. J. Exp. Med. 165:1987;641-649.
26. Whipple, D.L., Klemens, S.P., Cynamon, M.H., 1991. Development of the beige mouse as an animal model for M. paratuberculosis infection. In: Proc. 3rd Int. Colloq. Paratuberculosis, International Association of Paratuberculosis Inc., Providence, RI, pp. 551-552.